Europe Blood Plasma Derivatives Market Size & Share to, 2028

Europe Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 91 | Format: PDF | Report ID: KBV-20732

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Blood Plasma Derivatives Market

Market Report Description

The Europe Blood Plasma Derivatives Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).

Plasma, or blood plasma, is the liquid component of blood. Plasma functions as a transport medium for providing nutrients to the cells of the different organs of the body and for transferring metabolic waste products to the liver, kidneys, and lungs for elimination. It is also a blood cell transport mechanism and plays a crucial function in maintaining appropriate blood pressure.

Plasma helps maintain homeostasis, also called biological stability, including the acid-base balance within the blood and organism. Blood cells, including white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes), are isolated from whole blood to produce plasma. The residual straw-colored fluid comprises a significant amount of water, but it also includes essential solutes required for life. Electrolytes, like sodium, potassium, magnesium, bicarbonate, and calcium are important ingredients.

In addition, traces of amino acids, organic acids, vitamins, pigments, and enzymes are present. The endocrine system secretes hormones such as corticosteroids, insulin, and thyroxine into the blood. Hormone plasma concentrations must be carefully managed for optimal health. With renal failure, the amount of nitrogenous wastes (such as urea and creatinine) delivered to the kidney for excretion increases significantly.

The increasing government, as well as international support in the European countries in order to improve plasma research and uses, would accelerate the growth of the blood plasma derivatives market in the region. FDA has MRAs in place with the European Union and the United Kingdom. Since 2014, the FDA and the EU have partnered to study how each authority inspects drug producers and the risks and advantages of mutual recognition of drug inspections. The increasing focus of government along with various public organizations would drive the growth of the regional market.

The Germany market dominated the Europe Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $4,815.1 Million by 2028. The UK market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 9.9% during (2022 - 2028).

Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Blood Plasma Derivatives Market will Hit $72.5 Billion by 2028, at a CAGR of 9.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Immunodeficiency Diseases
  • Hypogammaglobulinemia
  • Hemophilia
  • Von Willebrand's Disease
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Type

  • Immunoglobulin
  • Albumin
  • Factor VIII
  • Factor IX
  • Hyperimmune Globulin
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Bayer AG
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • Biotest AG
  • LFB S.A.
  • CSL Limited
  • Octapharma AG
  • Kedrion S.p.A
  • Sanofi S.A.
  • Fusion Health Care Pvt. Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Blood Plasma Derivatives Market Report 2022-2028

North America Blood Plasma Derivatives Market Report 2022-2028

Asia Pacific Blood Plasma Derivatives Market Report 2022-2028

LAMEA Blood Plasma Derivatives Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities